Annual accounts
Total Exemption Full accounts
31/03/2027Filing deadline
Made up to 30/06/2025Due 31/03/2027
- Next accounts made up to
- 30/06/2026
- Last accounts made up to
- 30/06/2025
ENDOCRINE PHARMACEUTICALS LIMITED
Active- 03005721Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Wilderness End, Tadley Common Road, Tadley, Hampshire RG26 3TA
- Classification (SIC)
- Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 16/03/2026View PDF (3 pages)
Confirmation statement made on 2026-03-15 with no updates
- 12/09/2025View PDF (8 pages)
Total exemption full accounts made up to 2025-06-30
- 17/03/2025View PDF (15 pages)
Confirmation statement made on 2025-03-15 with updates
- 29/08/2024View PDF (8 pages)
Total exemption full accounts made up to 2024-06-30
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 15/03/2026
- Last statement dated
- 30/06/2025
Financial performance
The latest figures ENDOCRINE PHARMACEUTICALS LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£-99.31K2025
-10.30%vs 20242024: £-90.04K
Cash in Bank
£1.52K2025
-70.68%vs 20242024: £5.19K
Total Liabilities
£0.002025
No changevs 20242024: £0.00
Employees
32025
0vs 20242024: 3
Of the 3 measures with an earlier filing to compare against, 2 fell and 1 was unchanged. Net assets moved furthest, down 10.30% on 2024. See the full financial analysis for ENDOCRINE PHARMACEUTICALS LIMITED.
The full financial record
Three ways through ENDOCRINE PHARMACEUTICALS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -16.1% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved4 chartsCharts by indicator4 filed indicators plotted year by year, 2021–2025.Plot the figures5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 3 | 0 |
| 2024 | 3 | 0 |
| 2023 | 3 | 0 |
| 2022 | 3 | 0 |
| 2021 | 3 | – |
Reported employee count was unchanged at 3 between 2021 and 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
23Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 30/06/2020–Present | 20 | |
| Director | 07/04/1995–25/10/1996 | 15 | |
| Director | 27/03/2003–10/03/2006 | 4 | |
| Director | 11/05/2000–11/05/2001 | 11 | |
| Nominee Director | 04/01/1995–07/04/1995 | 4018 | |
| Director | 07/01/1995–25/10/1996 | 119 | |
| Director | 13/01/2014–Present | 11 | |
| Director | 08/10/1999–22/01/2004 | 10 | |
| Director | 03/06/1998–15/03/2004 | 4 | |
| Director | 11/09/2003–08/01/2013 | 11 | |
| Director | 08/10/1999–09/02/2000 | 3 | |
| Director | 10/03/2006–29/11/2006 | 11 | |
| Director | 28/06/2004–30/06/2020 | 39 | |
| Nominee Secretary | 04/01/1995–07/04/1995 | 27 | |
| Secretary | 08/10/1999–08/07/2005 | 1 | |
| Director | 22/05/1995–Present | 0 | |
| Director | 03/05/2001–27/03/2003 | 3 | |
| Secretary | 09/09/2005–Present | 0 | |
| Secretary | 25/10/1996–08/10/1999 | 0 | |
| Secretary | 07/04/1995–25/10/1996 | 0 | |
| Director | 17/07/1998–09/12/1999 | 2 | |
| Director | 22/11/1996–12/02/2004 | 1 | |
| Director | 17/07/1998–08/10/1999 | 0 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 04/01/2017–Present | 0 | |
| 04/01/2017–Present | 0 | |
| 05/01/2017–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 15 Since 14/11/2022
- Last 12 months
- 1 -1 vs the year before
- Most recent filing
- 16/03/2026 6 months ago
What changed in the last year
- Confirmation statementLatest 16/03/2026
Filing timeline
- 16/03/2026View PDF (3 pages)
Confirmation statement made on 2026-03-15 with no updates
- 12/09/2025View PDF (8 pages)
Total exemption full accounts made up to 2025-06-30
- 17/03/2025View PDF (15 pages)
Confirmation statement made on 2025-03-15 with updates
- 29/08/2024View PDF (8 pages)
Total exemption full accounts made up to 2024-06-30
- 15/08/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-02-19
- 15/08/2024View PDF (16 pages)
Confirmation statement made on 2024-03-15 with updates
- 08/01/2024View PDF (3 pages)
Confirmation statement made on 2024-01-04 with no updates
- 03/11/2023View PDF (8 pages)
Total exemption full accounts made up to 2023-06-30
- 08/03/2023View PDF (17 pages)
Confirmation statement made on 2023-01-04 with updates
- 06/03/2023View PDF (3 pages)
Statement of capital following an allotment of shares on 2022-01-05
- 06/03/2023View PDF (3 pages)
Statement of capital following an allotment of shares on 2022-01-05
- 09/02/2023View PDF (2 pages)
Withdrawal of a person with significant control statement on 2023-02-10
Showing 12 of 15 filings
See when the next accounts and confirmation statement are due
Similar companies
111 UK companies are similar to ENDOCRINE PHARMACEUTICALS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other research and experimental development on natural sciences and engineering) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
STAIRSTEADY LIMITED
ActiveAlison Business Centre, 39-40 Alison Crescent, Sheffield S2 1AS
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 05925853
- Incorporated
- 05/09/2006
- Employees
- 3
LAWSON SCIENTIFIC LIMITED
ActiveUnit 3 Clipstone Brook Industrial Estate, Cherrycourt Way, Leighton Buzzard LU7 4GP
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11438299
- Incorporated
- 28/06/2018
- Employees
- 4
AI ADAPTABILITY COACHING LTD
ActiveLinlarrock Rockbourne Road, Rockbourne, Fordingbridge, Dorset SP6 3NT
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 13602071
- Incorporated
- 03/09/2021
- Employees
- 3
AIR GIANTS LIMITED
ActiveUnit 17 Avonbank Industrial Centre, West Town Road, Bristol BS11 9DE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12572860
- Incorporated
- 27/04/2020
- Employees
- 4
LIXEA LIMITED
Active6th Floor One London Wall, London EC2Y 5EB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10839236
- Incorporated
- 28/06/2017
- Employees
- 3
About ENDOCRINE PHARMACEUTICALS LIMITED
A short description of the company, written from its Companies House record.
ENDOCRINE PHARMACEUTICALS LIMITED is a private limited company registered in the United Kingdom, based in Wilderness End, Tadley Common Road, Tadley, Hampshire RG26 3TA. Companies House classifies its business as Other research and experimental development on natural sciences and engineering. It has been on the register for 31 years 8 months.
The register currently records it as active. Its 2025 accounts report net assets of £-99.31K and 3 employees.
ENDOCRINE PHARMACEUTICALS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does ENDOCRINE PHARMACEUTICALS LIMITED do?
Companies House records ENDOCRINE PHARMACEUTICALS LIMITED under one registered business activity: Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007).
Is ENDOCRINE PHARMACEUTICALS LIMITED still active?
ENDOCRINE PHARMACEUTICALS LIMITED is recorded as active on the Companies House register, and has been on it since 04/01/1995.
What are ENDOCRINE PHARMACEUTICALS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £-99.31K, cash in bank of £1.52K and total liabilities of £0.00.
When did ENDOCRINE PHARMACEUTICALS LIMITED last file with Companies House?
The most recent document on the record is dated 16/03/2026: Confirmation statement made on 2026-03-15 with no updates, 6 months ago.
When are ENDOCRINE PHARMACEUTICALS LIMITED's next filings due?
On the current registry record, accounts are due by 31/03/2027.
Who runs ENDOCRINE PHARMACEUTICALS LIMITED?
Companies House lists 23 officers (4 currently in post) and 3 people with significant control.